Anthocyanins

Compound Class	Anthocyanins — a subclass of flavonoids (glycosylated anthocyanidins)
Representative Members	Cyanidin, delphinidin, malvidin, pelargonidin, petunidin — each existing as multiple glycosides
Botanical Sources	Ribes nigrum (black currant), Vaccinium myrtillus (bilberry), Aristotelia chilensis (maqui), Oryza sativa (black rice), Clitoria ternatea (butterfly pea)
Plant Part(s)	Fruit (berries), seed hull (black rice), flower (butterfly pea)
Typical Standardisation	Total anthocyanins by pH-differential spectrophotometry, expressed as cyanidin-3-glucoside equivalents; 4–25% common commercial range
Primary Applications	Cardiometabolic support, vascular/endothelial function, ocular health, natural colorant systems
Claim Strength (Overview)	Moderate–High for cardiometabolic markers; Moderate for ocular claims
Buy from Herbuno	Anthocyanins 25% Powder (Black Currant Extract) | Standardized Ribes nigrum → Maqui Berry Extract Powder →

Name origin: The word anthocyanin was coined in 1835 by German pharmacist Ludwig Clamor Marquart from the Greek anthos (flower) and kyanos (dark blue), originally describing the blue pigment of cornflower petals before the term was broadened to the entire class of red–purple–blue flavonoid glycosides distributed across the plant kingdom. Traditional use: Anthocyanin-dense fruits carry independent folk histories on three continents — bilberry featured in European herbal texts for eye and circulatory complaints and in the (now-contested) WWII-era account of RAF pilots eating bilberry jam to sharpen night vision; maqui berry was used by the Mapuche people of Chile as a general tonic and wound dressing; black rice was reserved for Chinese emperors as a nutritive "forbidden rice"; and butterfly pea flower has long served as both a natural blue food dye and a mild nervine in Southeast Asian traditional medicine. Research trajectory: Anthocyanin research shifted from descriptive food-colorant chemistry in the early 20th century toward mechanistic cardiometabolic pharmacology from the 1990s onward, driven initially by French-paradox-era interest in polyphenols and grape/berry epidemiology, then accelerated by the isolation of purified anthocyanin fractions for RCT use. Commercial source: Black currant (Ribes nigrum) is the dominant commercial anthocyanin source at scale owing to its high total-anthocyanin yield and cold-climate cultivation economics, standardly extracted and assayed to a target total-anthocyanin percentage; maqui berry is marketed as a higher-potency, delphinidin-rich niche alternative.

---

Evidence for Anthocyanins Applications

Anthocyanins are among the most extensively studied dietary flavonoid subclasses for cardiometabolic outcomes, with evidence spanning purified-compound RCTs and large prospective cohorts. A pooled analysis of randomized controlled trials found that purified anthocyanin supplementation produced measurable reductions in LDL cholesterol and triglycerides alongside an increase in HDL cholesterol, while parallel analysis of prospective cohort data linked higher habitual anthocyanin intake to lower risk of coronary heart disease and total cardiovascular mortality (Frontiers Nutr 2021). Claim strength: Moderate–High.

A separate systematic review and meta-analysis focused specifically on randomized controlled trial data reported that anthocyanin treatment was associated with decreases in both LDL and total cholesterol, with a marginal increase in HDL, though the same analysis found no significant pooled effect on blood pressure or the inflammatory markers CRP, TNF-α, and IL-6 — an important nuance for formulators making inflammation-specific claims (Yang 2017 Adv Nutr). The mechanistic picture centres on anthocyanins improving endothelial nitric oxide bioavailability and reducing LDL oxidative susceptibility, rather than acting as broad-spectrum anti-inflammatories, which is a materially different mechanism than the nitrate-driven vasodilation seen in betalain-rich beetroot products. Claim strength: Moderate.

Bioavailability remains the central formulation constraint for this class. Native anthocyanin glycosides undergo extensive first-pass metabolism, with only a small fraction (typically well under 5%) of ingested dose recovered intact in plasma; the majority is degraded to phenolic acid catabolites in the colon before absorption, meaning much of the measured systemic activity likely derives from these downstream metabolites rather than the parent glycosides. This has direct implications for dosing intervals and for interpreting in-vitro potency data, which typically use concentrations of intact anthocyanins far above what is achievable in human plasma. Claim strength: Moderate.

Anthocyanidin aglycones (the sugar-free backbone) appear to drive a disproportionate share of the cardioprotective signal compared to their parent glycosides in subgroup analyses of the cohort literature, which has prompted some formulators to favour extracts standardized to total anthocyanidins after acid hydrolysis rather than native glycoside content — a distinction worth specifying on any certificate of analysis, since the two assay methods are not interchangeable and can yield different percentage figures from the same raw material. Claim strength: Moderate.

Ocular applications, historically the most commercially prominent anthocyanin claim via bilberry, rest on a comparatively thinner evidentiary base than the cardiometabolic literature: most supportive data derive from older, small, methodologically heterogeneous European trials rather than the large modern meta-analyses now available for cardiometabolic endpoints, and contemporary systematic reviews have generally been unable to confirm a clinically meaningful effect on night vision in healthy adults. Formulators should weight cardiometabolic claims more heavily than visual-acuity claims when working with anthocyanin-standardized extracts. Claim strength: Emerging.

---

Dosage & Formulator Specification

Commercial anthocyanin extracts are standardized predominantly from black currant, bilberry, and maqui berry, with total-anthocyanin content typically assayed by pH-differential spectrophotometry and reported as cyanidin-3-glucoside equivalents. Grades in the 4–25% range are common in the trade; black currant tends to anchor the mid-range (around 25% is achievable at scale), while maqui and bilberry are often sold at lower percentages but marketed on distinct anthocyanidin profiles (maqui is comparatively delphinidin-rich). Buyers should always confirm whether a stated percentage reflects native glycosides or acid-hydrolyzed aglycones, since these are materially different numbers from the same starting material.

Clinical trial dosing in the cardiometabolic literature has generally used purified anthocyanin doses in the range of roughly 80–320 mg/day of total anthocyanins, sustained over periods from several weeks to several months, though study designs vary considerably in extract source and standardization method, which limits direct dose comparability across the literature. Formulators translating this into finished-product specifications should work backward from the specific extract’s assayed percentage rather than assuming interchangeability between black-currant-, bilberry-, and maqui-derived material.

Analytical verification should specify both the assay method (HPLC vs. pH-differential spectrophotometry) and the reference standard used, as batch-to-batch anthocyanin content in fruit-derived extracts can vary meaningfully with harvest year, cultivar, and post-harvest handling given the compound class's known instability to heat, light, and pH drift. Cold-chain or protected storage and light-blocking packaging are standard mitigations for finished anthocyanin-standardized powders.

Anthocyanins are generally well tolerated at food-equivalent and supplemental intakes, with the primary formulation caution being chemical stability rather than safety: degradation accelerates in aqueous, high-pH, or heat-exposed matrices, which should inform delivery-format selection (dry capsule/tablet formats generally outperform ready-to-drink liquid formats for shelf stability). No systematic drug-interaction signal has been established at typical dietary-supplement intakes, though anthocyanin-rich extracts are sometimes combined with other polyphenol classes in cardiometabolic-support formulations, warranting standard label disclosure of total combined polyphenol load.

---

Frequently Asked Questions — Anthocyanins

What is the difference between an anthocyanin and an anthocyanidin?
An anthocyanidin is the sugar-free flavylium core structure (e.g. cyanidin, delphinidin), while an anthocyanin is the glycosylated form found in plants, where one or more sugar molecules are attached to that core. Commercial extracts are typically standardized to one or the other depending on assay method, and the two figures are not interchangeable on a certificate of analysis.

Why does black currant dominate commercial anthocyanin supply over other sources?
Black currant offers a favourable combination of high total-anthocyanin yield per unit of raw material, established cold-climate cultivation infrastructure in Europe, and consistent assayable standardization, making it more economically scalable than lower-yield or geographically constrained sources like maqui berry or bilberry.

Do anthocyanins survive digestion intact?
Only a small fraction of ingested anthocyanin glycosides is recovered intact in human plasma; most is metabolized by gut microbiota into phenolic acid catabolites before systemic absorption. This means a meaningful share of measured physiological activity likely derives from these downstream metabolites rather than the parent compounds measured on a label.

Can anthocyanin extracts be combined with other polyphenol-class ingredients in one formulation?
Yes, anthocyanins are commonly formulated alongside other polyphenol classes such as proanthocyanidins or catechins in cardiometabolic-support products, though total combined polyphenol load should be disclosed on the label and stability testing should account for potential interactions in aqueous or heat-exposed delivery formats.

Related compounds: Quercetin, Resveratrol, Cyanidin, Polyphenols

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery